查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1950471

全球柔软性胃肠内视镜设备市场（按设备类型、内视镜类型、技术、应用、最终用户和销售管道划分），2026-2032年预测

Flexible Gastrointestinal Endoscopic Devices Market by Device Type, Endoscopy Type, Technology, Applications, End Users, Sales Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，柔性胃肠内视镜设备市场价值将达到 31.5 亿美元，到 2026 年将成长至 34.8 亿美元，到 2032 年将达到 62.5 亿美元，复合年增长率为 10.28%。

关键市场统计数据
基准年 2025 31.5亿美元
预计年份：2026年 34.8亿美元
预测年份 2032 62.5亿美元
复合年增长率 (%) 10.28%

随着人们对安全性、易用性和经济性的期望日益提高，现代化的、柔软性的胃肠内视镜设备正在重塑临床工作流程和商业性重点。

柔软性胃肠内视镜设备如今在临床需求、技术创新和医疗保健系统经济的交汇点上发挥核心作用。这些设备旨在可视化和治疗整个胃肠道的病变，已从简单的诊断工具发展成为支持日益广泛的治疗性介入的多功能平台。因此，设备开发商、医院系统、门诊手术中心和门诊诊所必须在一个快速变化的生态系统中寻求平衡，在这个生态系统中，临床疗效、用户人体工学、感染控制和总体拥有成本 (TCO) 等因素都需引起重视。

成像精度的显着提高、一次性设备的广泛应用、自动化以及数据驱动的工作流程等关键转折点，正在重新定义内视镜检查的实践和竞争格局。

柔软性胃肠内视镜装置领域正经历一系列变革，重塑临床实务和市场竞争格局。高解析度成像技术和组织表征技术等成像和光学技术的进步，提高了病灶检出率和诊断信心。同时，动力插入机制和其他机械创新也改善了操作的人体工学和操作一致性，使临床医生能够以更高的精度和更小的身体负担完成更复杂的手术操作。

不断变化的关税政策和贸易趋势对内视镜价值链的策略影响：对供应链韧性、筹资策略和购买行为的影响

美国2025年预计的关税调整和贸易政策转变正促使人们对支持柔软性胃肠内视镜设备的整个供应链进行策略性重新评估。传统上依赖跨境製造和零件采购的公司正面临不断上涨的进口关税、更长的前置作业时间和日益复杂的行政流程。为此，许多製造商和经销商正在探索各种方案，例如在免税地区委託製造、近岸外包和垂直整合，以维持利润率和供应的连续性。

从设备外形、手术目标、技术模式、临床应用、使用者环境和分销管道等方面进行全面的观点，并与策略重点保持一致。

对市场区隔的深刻理解会影响产品开发和商业策略。依设备类型划分，市场包括大肠镜、十二指肠镜、小肠镜和胃镜，每种设备可进一步细分为一次性使用和可重复使用。这造就了独特的临床和操作应用场景，进而影响购买决策。根据内视镜类型，设备可用于诊断和治疗性介入。诊断应用场景可细分为切片检查和影像检查，而治疗应用场景包括止血、息肉切除、支架置入和食道静脉曲张结扎术，每项应用都需要与专用配件相容并确保操作的可靠性。

区域管理体制、临床实践模式和製造生态系统如何塑造全球市场中不同的应用路径和商业策略

区域差异显着影响着柔性胃肠内视镜设备的研发、核准和应用。在美洲，法规结构和报销模式侧重于临床疗效和手术效率，而成熟的私人医疗机构市场和大规模的医院网络则为高端可重复使用平台和实用的一次性解决方案都创造了机会。研发活动集中在领先的学术机构，这些机构往往是早期采用者和具有影响力的意见领袖，影响着全部区域的指南和采购路径。

竞争动态和策略定位洞察，揭示产品系列、生产规模、临床证据和服务模式如何决定市场领导地位。

柔软性胃肠内视镜器材的竞争格局由成熟的医疗技术领导者、专业器材公司和提供精准创新的敏捷型新创公司共同构成。竞争对手透过Start-Ups来区分彼此，这些产品组合突出了整合可视化功能和配件的综合平台解决方案，或专注于抛弃式、增强型光学元件和电动插入技术的细分产品。那些优先考虑强有力的临床证据产生、简化监管流程和可扩展生产能力的公司，持续降低了市场进入门槛，并建立了永续的客户关係。

为行业领导者提供可操作的策略性倡议和营运重点，以确保韧性、加速产品应用并推动临床差异化。

产业领导者必须采取果断、有针对性的策略行动，将颠覆性趋势转化为永续优势。首先，优先考虑模组化平台设计，以便快速更换一次性组件、先进成像模组和插入子系统。这将缩短增量升级的上市时间，并简化监理申报流程。其次，实现生产和采购基础多元化，纳入区域契约製造製造商和替代供应商，以降低关税波动和物流中断带来的风险。第三，投资于高品质、经同行评审的临床研究，以证明诊断准确性、手术效率和安全性方面的实际改进，因为采购委员会越来越需要可靠的真实世界数据（RWE）。

我们采用稳健的多方面研究途径，结合临床见解、监管和专利分析以及基于情境的检验，为实际的策略决策提供支援。

我们的基础调查方法整合了多方面的证据来源，以得出严谨而令人信服的结论。主要研究包括对临床关键管理人员、采购经理、医疗设备技术经理和供应链高阶主管进行结构化访谈和保密咨询，以揭示营运挑战、应用标准和服务期望。专家小组和顾问委员会为新兴技术提供了临床背景，并检验了流程和培训要求的假设。我们将这些定性资料与来自同侪审查的临床文献、监管文件、专利概况和医疗设备註册资料的二手资料进行三角验证，以确保技术和效能声明得到支持。

对临床、营运和策略需求的综合分析凸显了整合产品、供应链和实证策略对于产生持久影响的重要性。

柔软性胃肠内视镜设备的整体发展格局呈现出技术快速进步与营运和监管审查日益严格的态势。视觉化方法、插入机制和数据分析的进步提升了临床应用能力，同时也引发了人们对消毒、供应稳定性和生命週期经济性的思考。随着医疗服务提供者和支付方越来越关注疗效和效率，製造商必须在高性能设计、实用服务模式和多样化的生产策略之间取得平衡。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 依设备类型柔软性胃肠内视镜设备市场

  • 大肠镜检查
  • 十二指肠镜
  • 肠镜检查
  • 胃镜

第九章 依内视镜类型柔软性胃肠内视镜设备市场

  • 诊断
    • 切片检查
    • 影像诊断
  • 治疗
    • 止血
    • 息肉切除术
    • 支架置入
    • 静脉曲张结扎术

第十章 依技术柔软性胃肠内视镜设备市场

  • 插入技术
    • 电插入法
    • 标准插页
  • 视觉化技术
    • 4K成像
    • 自动萤光精华
    • 高画质
    • 窄频成像

第十一章 依应用分類的柔软性胃肠内视镜设备市场

  • 诊断影像
  • 去除异物
  • 出血控制
  • 息肉检测
  • 狭窄扩张
  • 组织切片检查

第十二章 依最终用户柔软性胃肠内视镜设备市场

  • 门诊手术中心
  • 诊所
  • 医院

第十三章柔软性胃肠内视镜设备市场（依销售管道划分）

  • 直销
  • 批发商
  • 电子商务

第十四章 各地区柔软性胃肠内视镜设备市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十五章柔软性胃肠内视镜设备市场（按类别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十六章 各国柔软性胃肠内视镜设备市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

17. 美国柔软性胃肠内视镜设备市场

第十八章 中国柔软性胃肠内视镜设备市场

第十九章 竞争情势

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Ambu A/S
  • ATMOS MedizinTechnik GmbH & Co. KG
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • ConMed Corporation
  • Cook Medical LLC
  • EndoMed Systems GmbH
  • Erbe Elektromedizin GmbH
  • Fujifilm Holdings Corporation
  • HOYA Corporation
  • Johnson & Johnson
  • KARL STORZ SE & Co. KG
  • Laborie Medical
  • Medtronic plc
  • Olympus Corporation
  • Richard Wolf GmbH
  • Smith & Nephew plc
  • Stryker Corporation
Product Code: MRR-4F7A6D4FD885

The Flexible Gastrointestinal Endoscopic Devices Market was valued at USD 3.15 billion in 2025 and is projected to grow to USD 3.48 billion in 2026, with a CAGR of 10.28%, reaching USD 6.25 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 3.15 billion
Estimated Year [2026] USD 3.48 billion
Forecast Year [2032] USD 6.25 billion
CAGR (%) 10.28%

How modern flexible gastrointestinal endoscopic devices reshape clinical workflows and commercial priorities amid evolving safety, usability, and economic expectations

Flexible gastrointestinal endoscopic devices now occupy a central role at the intersection of clinical need, technological innovation, and health system economics. These devices, designed to visualize and treat pathology throughout the tubular gastrointestinal tract, have evolved from solely diagnostic tools into multi-functional platforms that support a widening array of therapeutic interventions. As a result, device developers, hospital systems, ambulatory surgical centers, and outpatient clinics must navigate a rapidly changing ecosystem in which clinical efficacy, user ergonomics, infection control, and total cost of ownership compete for attention.

Clinicians increasingly demand instruments that improve lesion detection while reducing procedure time and operator fatigue. At the same time, hospital procurement teams emphasize lifecycle costs, sterilization workflows, and supply reliability. This dual pressure creates fertile ground for innovation across disposable and reusable models, enhanced visualization modalities, and insertion technologies that reduce variability and procedural risk. Regulatory agencies have concurrently tightened expectations for device reprocessing and post-market surveillance, driving greater transparency and compliance burdens for manufacturers and providers alike.

Consequently, strategic leaders should view endoscopic device development through a systems lens that incorporates clinical pathways, device interoperability, service models, and environmental impact. By aligning product design with the pragmatic requirements of end users and the evolving regulatory landscape, companies can both accelerate adoption and mitigate downstream operational friction. As stakeholders adapt, the market will reward solutions that balance clinical performance with pragmatic, scalable commercial models.

Key inflection points in imaging accuracy, single-use device adoption, automation, and data-driven workflows that are redefining endoscopy practice and competition

The landscape for flexible gastrointestinal endoscopic devices is experiencing a set of transformative shifts that are reshaping clinical practice and competitive dynamics. Advances in imaging and optics, such as higher-resolution modalities and tissue characterization techniques, have improved lesion detection and diagnostic confidence. Simultaneously, motorized insertion and other mechanical innovations are altering ergonomics and procedural consistency, enabling clinicians to undertake more complex interventions with greater precision and less physical strain.

Concurrently, single-use disposable platforms have emerged as a strategic response to infection prevention concerns and reprocessing constraints, prompting reassessment of clinical protocols and supply chain models. Artificial intelligence and computer-assisted detection are maturing from pilot projects into integrated workflow tools that prioritize suspicion areas and standardize reporting. In parallel, connectivity and data analytics are enabling remote proctoring, tele-endoscopy, and more systematic performance benchmarking across institutions.

Market dynamics are also changing in response to broader healthcare trends. Value-based care models emphasize outcomes and efficiency, encouraging adoption of technologies that demonstrably reduce repeat procedures and complications. Procurement teams are increasingly sophisticated, demanding evidence of real-world impact and predictable service economics. As a result, vendors must combine clinical evidence generation with flexible commercial arrangements and scalable manufacturing approaches. Taken together, these trends signify a pivot from incremental device improvement toward platform-level innovation and services that integrate devices into holistic clinical pathways.

Strategic consequences of evolving tariff policies and trade dynamics on supply chain resilience, sourcing strategies, and procurement behavior across the endoscopy value chain

Anticipated tariff changes and trade policy shifts in the United States for 2025 have catalyzed strategic reassessment across the supply chains that support flexible gastrointestinal endoscopic devices. Firms that historically relied on cross-border manufacturing and component sourcing are confronting higher import duties, longer lead times, and increased administrative complexity. In response, many manufacturers and distributors are evaluating options such as contract manufacturing in tariff-exempt jurisdictions, nearshoring, or vertical integration to preserve margin and continuity of supply.

These dynamics cascade into procurement behavior at hospitals, ambulatory surgical centers, and clinics. Purchasing teams respond to cost pressure by demanding greater transparency around landed costs, warranty terms, and post-market service commitments. Moreover, facilities place higher strategic value on suppliers that demonstrate diversified manufacturing footprints and proven contingency plans. For smaller innovators and start-ups, tariff volatility can be particularly disruptive, increasing barriers to entry and complicating clinical trial logistics for regulated devices.

Regulatory compliance and customs documentation have become operational priorities, since misclassification and paperwork errors can exacerbate delays and penalties. Meanwhile, clinical adoption may shift toward devices that can be sourced domestically or regionally, accelerating interest in single-use alternatives that simplify logistics and reprocessing burdens. In short, evolving tariff environments are not just cost events; they are strategic inflection points that influence manufacturing strategy, commercial partnerships, and long-term positioning in the endoscopy ecosystem.

Integrated segmentation perspectives that align device form factors, procedural intent, technology modalities, clinical applications, user settings, and distribution channels to strategic priorities

A nuanced understanding of how the market segments informs both product development and commercial strategy. Based on device type, the market includes colonoscopes, duodenoscopes, enteroscopes, and gastroscopes, and each of these is further differentiated across disposable and reusable formats, creating distinct clinical and operational use cases that influence purchasing decisions. Based on endoscopy type, devices support diagnostic procedures and therapeutic interventions, with diagnostic use cases further subdivided into biopsy and imaging, while therapeutic procedures encompass hemostasis, polypectomy, stent placement, and variceal ligation, each demanding specialized accessory compatibility and procedural reliability.

From a technology perspective, the landscape divides into insertion technology and visualization technology, where insertion options range from motorized insertion to standard manual techniques, and visualization spans 4K imaging, autofluorescence, high-definition, and narrow band imaging; these technological choices affect lesion detectability, workflow integration, and training requirements. Application-driven segmentation captures diagnostic imaging, foreign body removal, hemorrhage control, polyp detection, stricture dilation, and tissue biopsy, demonstrating that devices must be versatile enough to address both routine screening and complex interventional cases. End users include ambulatory surgical centers, clinics, and hospitals, each with distinct purchasing cycles, budget constraints, and procedural volumes that shape the economics of disposables versus reusable systems.

Finally, sales channels range from direct sales to distributor networks and e-commerce platforms, and channel strategy materially affects market access, service delivery, and aftermarket revenue. Together, these segmentation layers create a matrix of clinical needs and commercial levers; successful products align design features, evidence generation, and distribution approaches with the priority use cases and procurement realities of target end users, thereby accelerating adoption and ensuring operational sustainability.

How regional regulatory regimes, clinical practice patterns, and manufacturing ecosystems shape differentiated adoption pathways and commercial strategies across global markets

Regional variation strongly influences how flexible gastrointestinal endoscopic devices are developed, approved, and adopted. In the Americas, regulatory frameworks and reimbursement models put a premium on clinical outcomes and procedural efficiency, while a mature private provider market and substantial hospital networks create opportunities for both premium reusable platforms and pragmatic single-use solutions. Research and clinical trial activity is concentrated in major academic centers, which often act as early adopters and influential opinion leaders, shaping guidelines and procurement pathways across the region.

In Europe, Middle East & Africa, fragmented reimbursement systems and heterogeneous regulatory environments encourage flexible commercialization strategies that combine centralized evidence generation with region-specific market entry plans. Emerging markets within the region are price sensitive yet increasingly prioritize investments that reduce infection risk and operating room turnaround time, making single-use technologies and robust sterilization services particularly attractive. In contrast, established Western European systems emphasize long-term cost-effectiveness and environmental considerations, prompting manufacturers to address lifecycle impacts.

Asia-Pacific exhibits rapid adoption of advanced visualization and digital integration, driven by high procedure volumes, expanding private healthcare sectors, and active domestic manufacturing ecosystems. Local manufacturers and contract manufacturers play a significant role in supply chains, and regulatory pathways in several jurisdictions have shortened approval timelines for incremental device updates. Across these regions, differences in clinical practice patterns, reimbursement, and manufacturing capacity require nuanced go-to-market approaches that balance global platform consistency with tailored regional execution.

Competitive dynamics and strategic positioning insights that reveal how product portfolios, manufacturing scale, clinical evidence, and service models determine market leadership

The competitive environment for flexible gastrointestinal endoscopic devices is defined by a mix of established medtech leaders, specialist device firms, and agile startups bringing targeted innovations. Competitors differentiate through portfolios that emphasize either comprehensive platform solutions with integrated visualization and accessories or niche offerings focused on single-use disposables, enhanced optics, or motorized insertion technologies. Companies that have prioritized robust clinical evidence generation, streamlined regulatory pathways, and scalable manufacturing capabilities consistently reduce adoption friction and build durable customer relationships.

Strategic plays within the sector include vertical integration to secure critical components and post-sale services, licensing arrangements to accelerate technology pairing with complementary platforms, and partnerships with clinical centers for real-world evidence collection. Intellectual property positions around insertion mechanics, sterilization methods, and imaging enhancements serve as important barriers to entry, while open interoperability and software-enabled analytics are becoming key differentiators. Firms that invest in comprehensive training programs and service models that minimize downtime create stickier customer relationships, particularly among high-volume hospital systems and ambulatory surgical centers.

Emerging firms often focus on a narrow clinical pain point-such as reducing infection risk or improving polyp detection-and use that focused value proposition to secure footholds. As competition intensifies, the ability to combine clinical performance with reliable supply, regulatory clarity, and attractive commercial terms will determine which companies capture long-term value in the ecosystem.

Actionable strategic initiatives and operational priorities that industry leaders should implement to secure resilience, accelerate adoption, and drive clinical differentiation

Industry leaders must act decisively to translate disruptive trends into sustainable advantage through targeted strategic moves. First, prioritize modular platform design that allows rapid interchange of disposable components, advanced imaging modules, and insertion sub-systems; this reduces time-to-market for incremental upgrades and eases regulatory submissions. Second, diversify manufacturing and sourcing footprints to include regional contract manufacturers and contingency suppliers, thereby reducing exposure to tariff volatility and logistics disruptions. Third, invest in high-quality, peer-reviewed clinical studies that demonstrate tangible improvements in diagnostic yield, procedural efficiency, or safety outcomes, since procurement committees increasingly demand robust real-world evidence.

Fourth, develop flexible commercial models that blend direct sales with distributor partnerships and e-commerce channels, tailoring offerings to the specific needs of ambulatory surgical centers, clinics, and hospitals. Fifth, accelerate digital integration by embedding AI-assisted detection and procedure documentation tools into device workflows to enhance clinician productivity and support quality programs. Sixth, establish comprehensive post-market service and training programs to improve uptime and operator proficiency, which fosters longer-term relationships and aftermarket revenue. Seventh, engage proactively with regulatory bodies and standards-setting organizations to shape pragmatic reprocessing and device-safety expectations, helping to reduce uncertainty for both manufacturers and providers.

Finally, incorporate environmental and lifecycle considerations into product roadmaps by exploring recyclable materials and take-back programs where feasible, while balancing infection control imperatives. By following these recommendations, industry leaders can strengthen resilience, differentiate clinically, and create commercially compelling propositions across a range of end user settings.

A robust, multi-method research approach combining primary clinical insights, regulatory and patent analysis, and scenario-driven validation to support practical strategic decisions

The underlying research methodology integrates multiple evidence streams to deliver rigorous, defensible insights. Primary research included structured interviews and confidential consultations with clinical key opinion leaders, procurement directors, biomedical engineering leads, and supply chain executives to surface operational pain points, adoption criteria, and service expectations. Expert panels and advisory boards provided clinical context for emerging technologies and validated assumptions about procedural workflows and training requirements. These qualitative inputs were triangulated with secondary data drawn from peer-reviewed clinical literature, regulatory filings, patent landscapes, and device registries to ensure technical assertions and performance claims were corroborated.

Analytical methods incorporated scenario planning and sensitivity analysis to explore how variables such as tariff changes, reimbursement shifts, and technology adoption curves could affect strategic outcomes without producing market estimates. Competitive benchmarking employed product feature matrices, regulatory milestones, and public disclosures to map capability gaps and identify potential partnership pathways. Validation steps included cross-referencing interview findings with clinical trial outcomes, device safety databases, and manufacturing capacity indicators to reduce bias and enhance reliability. The geographic scope covered major regional markets with attention to regulatory nuances and distribution models, and the temporal scope reflected the most recent clinical and policy developments up to mid-2024.

Finally, findings were subject to internal peer review and editorial quality control to ensure clarity, accuracy, and practical relevance for commercial and clinical stakeholders seeking to make informed decisions in a dynamic environment.

Synthesis of clinical, operational, and strategic imperatives that underscore the importance of integrated product, supply chain, and evidence strategies for lasting impact

The cumulative picture for flexible gastrointestinal endoscopic devices is one of rapid technical progress intersecting with heightened operational and regulatory scrutiny. Advances in visualization modalities, insertion mechanics, and data analytics are improving clinical capabilities while simultaneously raising considerations around sterilization, supply resilience, and lifecycle economics. As healthcare providers and payers place greater emphasis on outcomes and efficiency, manufacturers must reconcile high-performance design with practical service models and diversified manufacturing strategies.

Strategically, the most successful participants will be those that deliver demonstrable clinical value, build resilient supply chains that mitigate trade and tariff risk, and adopt flexible commercialization channels aligned to the specific needs of hospitals, ambulatory surgical centers, and clinics. Evidence generation and training programs remain critical enablers of adoption, and proactive engagement with regulatory and standards bodies can reduce friction for both reusable and single-use solutions. For clinical leaders, the imperative is to balance innovation adoption with robust infection prevention and cost-control mechanisms.

Ultimately, the market rewards solutions that treat devices as part of an integrated care pathway rather than standalone instruments. Organizations that align product development, manufacturing, clinical evidence, and commercial execution around this systems perspective will be best positioned to capitalize on technological advances while navigating operational headwinds.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Flexible Gastrointestinal Endoscopic Devices Market, by Device Type

  • 8.1. Colonoscopes
  • 8.2. Duodenoscopes
  • 8.3. Enteroscopes
  • 8.4. Gastroscopes

9. Flexible Gastrointestinal Endoscopic Devices Market, by Endoscopy Type

  • 9.1. Diagnostic
    • 9.1.1. Biopsy
    • 9.1.2. Imaging
  • 9.2. Therapeutic
    • 9.2.1. Hemostasis
    • 9.2.2. Polypectomy
    • 9.2.3. Stent Placement
    • 9.2.4. Variceal Ligation

10. Flexible Gastrointestinal Endoscopic Devices Market, by Technology

  • 10.1. Insertion Technology
    • 10.1.1. Motorized Insertion
    • 10.1.2. Standard Insertion
  • 10.2. Visualization Technology
    • 10.2.1. 4K Imaging
    • 10.2.2. Autofluorescence
    • 10.2.3. High Definition
    • 10.2.4. Narrow Band Imaging

11. Flexible Gastrointestinal Endoscopic Devices Market, by Applications

  • 11.1. Diagnostic Imaging
  • 11.2. Foreign Body Removal
  • 11.3. Hemorrhage Control
  • 11.4. Polyp Detection
  • 11.5. Stricture Dilation
  • 11.6. Tissue Biopsy

12. Flexible Gastrointestinal Endoscopic Devices Market, by End Users

  • 12.1. Ambulatory Surgical Centers
  • 12.2. Clinics
  • 12.3. Hospitals

13. Flexible Gastrointestinal Endoscopic Devices Market, by Sales Channel

  • 13.1. Direct Sales
  • 13.2. Distributors
  • 13.3. E-Commerce

14. Flexible Gastrointestinal Endoscopic Devices Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Flexible Gastrointestinal Endoscopic Devices Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Flexible Gastrointestinal Endoscopic Devices Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Flexible Gastrointestinal Endoscopic Devices Market

18. China Flexible Gastrointestinal Endoscopic Devices Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Ambu A/S
  • 19.6. ATMOS MedizinTechnik GmbH & Co. KG
  • 19.7. Becton, Dickinson and Company
  • 19.8. Boston Scientific Corporation
  • 19.9. ConMed Corporation
  • 19.10. Cook Medical LLC
  • 19.11. EndoMed Systems GmbH
  • 19.12. Erbe Elektromedizin GmbH
  • 19.13. Fujifilm Holdings Corporation
  • 19.14. HOYA Corporation
  • 19.15. Johnson & Johnson
  • 19.16. KARL STORZ SE & Co. KG
  • 19.17. Laborie Medical
  • 19.18. Medtronic plc
  • 19.19. Olympus Corporation
  • 19.20. Richard Wolf GmbH
  • 19.21. Smith & Nephew plc
  • 19.22. Stryker Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY ENDOSCOPY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY APPLICATIONS, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY END USERS, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY SALES CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY COLONOSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY COLONOSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY COLONOSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY DUODENOSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY DUODENOSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY DUODENOSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY ENTEROSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY ENTEROSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY ENTEROSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY GASTROSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY GASTROSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY GASTROSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY ENDOSCOPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY DIAGNOSTIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY DIAGNOSTIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY BIOPSY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY BIOPSY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY BIOPSY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY THERAPEUTIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY THERAPEUTIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY HEMOSTASIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY HEMOSTASIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY HEMOSTASIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY POLYPECTOMY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY POLYPECTOMY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY POLYPECTOMY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY STENT PLACEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY STENT PLACEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY STENT PLACEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY VARICEAL LIGATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY VARICEAL LIGATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY VARICEAL LIGATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY INSERTION TECHNOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY INSERTION TECHNOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY INSERTION TECHNOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY INSERTION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY MOTORIZED INSERTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY MOTORIZED INSERTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY MOTORIZED INSERTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY STANDARD INSERTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY STANDARD INSERTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY STANDARD INSERTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY VISUALIZATION TECHNOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY VISUALIZATION TECHNOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY VISUALIZATION TECHNOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY VISUALIZATION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY 4K IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY 4K IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY 4K IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY AUTOFLUORESCENCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY AUTOFLUORESCENCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY AUTOFLUORESCENCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY HIGH DEFINITION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY HIGH DEFINITION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY HIGH DEFINITION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY NARROW BAND IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY NARROW BAND IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY NARROW BAND IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY DIAGNOSTIC IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY DIAGNOSTIC IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY DIAGNOSTIC IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY FOREIGN BODY REMOVAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY FOREIGN BODY REMOVAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY FOREIGN BODY REMOVAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY HEMORRHAGE CONTROL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY HEMORRHAGE CONTROL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY HEMORRHAGE CONTROL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY POLYP DETECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY POLYP DETECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY POLYP DETECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY STRICTURE DILATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY STRICTURE DILATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY STRICTURE DILATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY TISSUE BIOPSY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY TISSUE BIOPSY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY TISSUE BIOPSY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY E-COMMERCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY E-COMMERCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY E-COMMERCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. AMERICAS FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 110. AMERICAS FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 111. AMERICAS FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY ENDOSCOPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. AMERICAS FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 113. AMERICAS FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 114. AMERICAS FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 115. AMERICAS FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY INSERTION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 116. AMERICAS FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY VISUALIZATION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 117. AMERICAS FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 118. AMERICAS FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 119. AMERICAS FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 120. NORTH AMERICA FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. NORTH AMERICA FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY ENDOSCOPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 124. NORTH AMERICA FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 125. NORTH AMERICA FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 126. NORTH AMERICA FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY INSERTION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 127. NORTH AMERICA FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY VISUALIZATION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 128. NORTH AMERICA FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 130. NORTH AMERICA FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 131. LATIN AMERICA FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. LATIN AMERICA FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. LATIN AMERICA FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY ENDOSCOPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. LATIN AMERICA FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 135. LATIN AMERICA FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 136. LATIN AMERICA FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 137. LATIN AMERICA FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY INSERTION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 138. LATIN AMERICA FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY VISUALIZATION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 139. LATIN AMERICA FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 140. LATIN AMERICA FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 141. LATIN AMERICA FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE, MIDDLE EAST & AFRICA FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE, MIDDLE EAST & AFRICA FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE, MIDDLE EAST & AFRICA FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY ENDOSCOPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY INSERTION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY VISUALIZATION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY ENDOSCOPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY INSERTION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY VISUALIZATION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 164. MIDDLE EAST FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 165. MIDDLE EAST FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. MIDDLE EAST FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY ENDOSCOPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 167. MIDDLE EAST FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 168. MIDDLE EAST FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 169. MIDDLE EAST FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 170. MIDDLE EAST FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY INSERTION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 171. MIDDLE EAST FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY VISUALIZATION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 172. MIDDLE EAST FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 173. MIDDLE EAST FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 174. MIDDLE EAST FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 175. AFRICA FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 176. AFRICA FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 177. AFRICA FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY ENDOSCOPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 178. AFRICA FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 179. AFRICA FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 180. AFRICA FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 181. AFRICA FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY INSERTION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 182. AFRICA FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY VISUALIZATION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 183. AFRICA FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 184. AFRICA FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 185. AFRICA FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 186. ASIA-PACIFIC FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 187. ASIA-PACIFIC FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 188. ASIA-PACIFIC FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY ENDOSCOPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 189. ASIA-PACIFIC FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 190. ASIA-PACIFIC FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 191. ASIA-PACIFIC FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 192. ASIA-PACIFIC FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY INSERTION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 193. ASIA-PACIFIC FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY VISUALIZATION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 194. ASIA-PACIFIC FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 195. ASIA-PACIFIC FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 196. ASIA-PACIFIC FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 197. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 198. ASEAN FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 199. ASEAN FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. ASEAN FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY ENDOSCOPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 201. ASEAN FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 202. ASEAN FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 203. ASEAN FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 204. ASEAN FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY INSERTION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 205. ASEAN FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY VISUALIZATION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 206. ASEAN FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 207. ASEAN FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 208. ASEAN FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 209. GCC FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 210. GCC FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 211. GCC FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY ENDOSCOPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 212. GCC FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 213. GCC FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 214. GCC FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 215. GCC FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY INSERTION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 216. GCC FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY VISUALIZATION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 217. GCC FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 218. GCC FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 219. GCC FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 220. EUROPEAN UNION FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPEAN UNION FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 222. EUROPEAN UNION FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY ENDOSCOPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPEAN UNION FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPEAN UNION FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 225. EUROPEAN UNION FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPEAN UNION FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY INSERTION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 227. EUROPEAN UNION FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY VISUALIZATION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 228. EUROPEAN UNION FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 229. EUROPEAN UNION FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 230. EUROPEAN UNION FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 231. BRICS FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 232. BRICS FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 233. BRICS FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY ENDOSCOPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 234. BRICS FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 235. BRICS FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 236. BRICS FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 237. BRICS FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY INSERTION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 238. BRICS FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY VISUALIZATION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 239. BRICS FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 240. BRICS FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 241. BRICS FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 242. G7 FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 243. G7 FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 244. G7 FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY ENDOSCOPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 245. G7 FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 246. G7 FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 247. G7 FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 248. G7 FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY INSERTION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 249. G7 FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY VISUALIZATION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 250. G7 FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 251. G7 FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 252. G7 FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 253. NATO FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 254. NATO FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 255. NATO FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY ENDOSCOPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 256. NATO FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 257. NATO FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 258. NATO FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 259. NATO FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY INSERTION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 260. NATO FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY VISUALIZATION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 261. NATO FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 262. NATO FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 263. NATO FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 264. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 265. UNITED STATES FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, 2018-2032 (USD